بحث بيانات أعضاء هيئة التدريس - جامعة الزقازيق

/ بحث بيانات أعضاء هيئة التدريس - جامعة الزقازيق

لايوجد

الموقع الشخصى
السيرة الذاتية

وائل محمد على على عبدالحليم

الكلية الصيدلة - القسم الميكروبيولوجى والمناعة
الميكروبيولوجي والمناعه

الدرجات العلمية

بكالوريوس فى الميكروبيولوجي والمناعه, -جامعة الزقازيق [2001]
ماجستير فى الميكروبيولوجي والمناعه, -جامعة الزقازيق [2006]
دكتوراه فى الميكروبيولوجي والمناعه, -جامعة أوسنابروك [2011]

الحالة الوظيفية الحالية :

معار

التدرج الوظيفى الأكاديمى

معيد : 26/11/2001
مدرس مساعد : 23/4/2006
مدرس : 28/2/2012
أستاذ مساعد : 28/11/2017
أستاذ : 27/12/2022

الأبحاث العلمية

1 - Studies on Pseudomonas Cepacia Isolated from Cystic Fibrosis Patients and Narural Sourses.

2 - Salmonella enterica as a vaccine carrier (1433).

3 - Potent therapeutic activity of a novel Salmonella-based cancer vaccine (1434).

4 - Evaluation of Salmonella enterica type III secretion system effector proteins as carriers for heterologous vaccine antigens (1433).

5 - Effective cancer vaccine platform based on attenuated salmonella and a type III secretion system (1435).

6 - Hepatitis C virus pathogenesis: Serum IL-33 level indicates liver damage (1436).

7 - Antibiotic resistance of Enterococcus faecalis and Enterococcus faecium isolated from urinary tract infections in Zagazig University hospitals (1437).

8 - Evaluation of the role of SsaV ‘Salmonella pathogenicity island-2 dependent type III secretion system components on the virulence behavior of Salmonella enterica serovar Typhimurium (1438).

9 - Targeting the virulence factors of Serratia marcescens by ambroxol (1438).

10 - Prevalence of multi-drug resistant Staphylococci isolated from surgical site infections (1439).

11 - Development of an Effective Cancer Vaccine Using Attenuated Salmonella and Type III Secretion System to Deliver Recombinant Tumor-Associated Antigens (1436).

12 - TALENs Construction: Slowly but Surely (1437).

13 - Diclofenac inhibits virulence of Proteus mirabilis isolated from diabetic foot ulcer (1437).

14 - Benzotriazole-Mediated Synthesis and Antibacterial Activity of Novel N-Acylcephalexins (1437).

15 - The Natural Flavonoid Fisetin Inhibits Cellular Proliferation of Hepatic, Colorectal, and Pancreatic Cancer Cells through Modulation of Multiple Signaling Pathways (1438).

16 - Investigating the influence of iron on Campylobacter jejuni transcriptome in response to acid stress (1441).

17 - Ciprofloxacin interferes with Salmonella Typhimurium intracellular survival and host virulence through repression of Salmonella pathogenicity island-2 (SPI-2) genes expression (1441).

18 - Repurposing anti-diabetic drug “Sitagliptin” as a novel virulence attenuating agent in Serratia marcescens (1441).

19 - Repurposing Anti-diabetic Drugs to Cripple Quorum Sensing in Pseudomonas aeruginosa (1442).

20 - Promising Antibiofilm Agents: Recent Breakthrough against Biofilm Producing Methicillin-Resistant Staphylococcus aureus (1442).

21 - Thymol Nanoemulsion: A New Therapeutic Option for Extensively Drug Resistant Foodborne Pathogens (1442).

22 - Pulmonary Targeting of Inhalable Moxifloxacin Microspheres for Effective Management of Tuberculosis (1442).

23 - Ciproloxacin interferes with Salmonella Typhimurium intracellular survival and host virulence through repression of Salmonella pathogenicity island-2 (SPI-2) genes expression (1441).

24 - Synthesis of Gold Nanoparticles by Using Green Machinery: Characterization and In Vitro Toxicity (1442).

25 - Pulmonary Targeting of Inhalable Moxifloxacin Microspheres for Effective Management of Tuberculosis (1442).

26 - Efficacy of SPG-ODN 1826 Nanovehicles in Inducing M1 Phenotype through TLR-9 Activation in Murine Alveolar J774A.1 Cells: Plausible Nano-Immunotherapy for Lung Carcinoma (1442).

27 - Xylitol Inhibits Growth and Blocks Virulence in Serratia marcescens (1442).

28 - Tackling Virulence of Pseudomonas aeruginosa by the Natural Furanone Sotolon (1442).

29 - Alteration of Salmonella enterica Virulence and Host Pathogenesis through Targeting sdiA by Using the CRISPR-Cas9 System (1443).

30 - A novel use of allopurinol as a quorum sensing inhibitor in Pseudomonas aeruginosa (1443).

31 - Alteration of Salmonella enterica Virulence and Host Pathogenesis through Targeting sdiA by Using the CRISPR-Cas9 System (1443).

32 - Retrospective Study of Bone-TB in Oman: 2002–2019 (1442).

33 - Anti-diabetics and antimicrobials: Harmony of mutual interplay (1443).

34 - Repurposing of antidiabetics as Serratia marcescens virulence inhibitors (1442).

35 - Not Only Antimicrobial: Metronidazole Mitigates the Virulence of Proteus mirabilis Isolated from Macerated Diabetic Foot Ulcer (1442).

36 - Controlling of Bacterial Virulence: Evaluation of Anti-Virulence Activities of Prazosin against Salmonella enterica (1444).

37 - Hiring of the Anti-Quorum Sensing Activities of Hypoglycemic Agent Linagliptin to Alleviate the Pseudomonas aeruginosa Pathogenesis (1444).

38 - Sodium Citrate Alleviates Virulence in Pseudomonas aeruginosa (1443).

39 - Anti-Quorum Sensing Activities of Gliptins against Pseudomonas aeruginosa and Staphylococcus aureus (1443).

40 - Clinical Resistant Strains of Enterococci and Their Correlation to Reduced Susceptibility to Biocides: Phenotypic and Genotypic Analysis of Macrolides, Lincosamides, and Streptogramins (1444).

41 - Biofilm Lifestyle in Recurrent Urinary Tract Infections (1444).

42 - Design, synthesis and antitumor evaluation of novel pyrazolo[3,4-d]pyrimidines incorporating different amino acid conjugates as potential DHFR inhibitors (1444).

43 - Hiring of the Anti-Quorum Sensing Activities of Hypoglycemic Agent Linagliptin to Alleviate the Pseudomonas aeruginosa Pathogenesis (1444).

44 - Human dihydrofolate reductase inhibition effect of 1-Phenylpyrazolo [3, 4–d] pyrimidines: Synthesis, antitumor evaluation and molecular modeling study (1444).

45 - Controlling of Bacterial Virulence: Evaluation of Anti-Virulence Activities of Prazosin against Salmonella enterica (1444).

46 - Characterization of the Anti-Biofilm and Anti-Quorum Sensing Activities of the β-Adrenoreceptor Antagonist Atenolol against Gram-Negative Bacterial Pathogens (1444).

47 - Silencing of Salmonella typhimurium Pathogenesis: Atenolol Acquires Efficient Anti-Virulence Activities (1444).

48 - Muting Bacterial Communication: Evaluation of Prazosin Anti-Quorum Sensing Activities against Gram-Negative Bacteria Pseudomonas aeruginosa, Proteus mirabilis, and Serratia marcescens (1444).

49 - Amphotericin B-PEG Conjugates of ZnO Nanoparticles: Enhancement Antifungal Activity with Minimal Toxicity (1444).

50 - Sodium Citrate Alleviates Virulence in Pseudomonas aeruginosa (1443).

51 - Anti-Quorum Sensing Activities of Gliptins against Pseudomonas aeruginosa and Staphylococcus aureus (1443).

52 - Terazosin Interferes with Quorum Sensing and Type Three Secretion System and Diminishes the Bacterial Espionage to Mitigate the Salmonella Typhimurium Pathogenesis (1443).

53 - Novel In Vivo Assessment of Antimicrobial Efficacy of Ciprofloxacin Loaded Mesoporous Silica Nanoparticles against Salmonella typhimurium Infection (1443).

54 - Repurposing α-Adrenoreceptor Blockers as Promising Anti-Virulence Agents in Gram-Negative Bacteria (1443).

55 - Synthesis, Antimicrobial, Anti-Virulence and Anticancer Evaluation of New 5(4H)-Oxazolone-Based Sulfonamides (1443).

56 - Computational and Biological Evaluation of β-Adrenoreceptor Blockers as Promising Bacterial Anti-Virulence Agents (1443).

57 - Clonal Diversity and Epidemiological Characteristics of ST239-MRSA Strains (1443).

58 - Elevated Levels of IL-33, IL-17 and IL-25 Indicate the Progression from Chronicity to Hepatocellular Carcinoma in Hepatitis C Virus Patients (1443).

59 - Characterization of the Anti-Biofilm and Anti-Quorum Sensing Activities of the β-Adrenoreceptor Antagonist Atenolol against Gram-Negative Bacterial Pathogens (1444).

60 - Silencing of Salmonella typhimurium Pathogenesis: Atenolol Acquires Efficient Anti-Virulence Activities (1444).

61 - Muting Bacterial Communication: Evaluation of Prazosin Anti-Quorum Sensing Activities against Gram-Negative Bacteria Pseudomonas aeruginosa, Proteus mirabilis, and Serratia marcescens (1444).

62 - Biofilm Lifestyle in Recurrent Urinary Tract Infections (1444).

63 - Clinical Resistant Strains of Enterococci and Their Correlation to Reduced Susceptibility to Biocides: Phenotypic and Genotypic Analysis of Macrolides, Lincosamides, and Streptogramins (1444).

64 - The Anti-Virulence Activities of the Antihypertensive Drug Propranolol in Light of Its Anti-Quorum Sensing Effects against Pseudomonas aeruginosa and Serratia marcescens (1445).

65 - Drug repositioning: doxazosin attenuates the virulence factors and biofilm formation in Gram-negative bacteria (1444).

66 - Diminishing the Pathogenesis of the Food-Borne Pathogen Serratia marcescens by Low Doses of Sodium Citrate (1444).

67 - Synergistic Benefits: Exploring the Anti-Virulence Effects of Metformin/Vildagliptin Antidiabetic Combination against Pseudomonas aeruginosa via Controlling Quorum Sensing Systems (1444).

68 - Relocating Glyceryl Trinitrate as an Anti-Virulence Agent against Pseudomonas aeruginosa and Serratia marcescens: Insights from Molecular and In Vivo Investigations (1445).

69 - The anti-staphylococcal fusidic acid as an efflux pump inhibitor combined with fluconazole against vaginal candidiasis in mouse model (1445).

70 - Urinary Tract Infections - New Insights (1445).

71 - A Prospective Cohort Study of COVID-19: Evaluation of the Early Role of IL-1 and IL-6 Antagonists in Improving the Outcome of the Illness and Reduction in the Risk of Death (1444).

72 - What’s old is new again: Insights into diabetic foot microbiome (1445).

73 - Analytical Methodologies for the Estimation of Oxazolidinone Antibiotics as Key Members of anti-MRSA Arsenal: A Decade in Review (1444).

74 - Antimicrobial and anti-virulence activities of 4-shogaol from grains of paradise against gram-negative bacteria: Integration of experimental and computational methods (1445).

75 - Drug repositioning: doxazosin attenuates the virulence factors and biofilm formation in Gram-negative bacteria (1444).

76 - The anti-staphylococcal fusidic acid as an efflux pump inhibitor combined with fluconazole against vaginal candidiasis in mouse model (1445).

المجالات البحثية